|
Search
Collections
Benchmarks
Upload document
BEV15
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 product
1 indication
Clinical trial
NCT01462890
Product
bevacizumab, oral cyclophosphamide
Indication
Ovarian Cancer
